EUVIMEDEUVIMED entdecken
Crossref

Influence of ursodeoxycholic acid on hepatic lipid deposition, blood glucose, and insulin levels in high-fat -fed Sprague–Dawley rats

Xiuping Bai, Yufeng Han, Lingyan Wei, Xiaojin Han, Feng Dong

Journal of Clinical and Translational Research · 08.09.2026 · 12 (5) · 026090015

DOI: 10.36922/jctr026090015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical and Translational Research, online erschienen am 08.09.2026. Verfasst von Xiuping Bai und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Metabolic dysfunction-associated steatotic liver disease (MASLD) is becoming a growing public health concern. MASLD often coexists with abnormal glucose metabolism. Currently, there is no standard treatment for MASLD.

Aim

To elucidate the influence of ursodeoxycholic acid (UDCA) on hepatic lipid deposition, blood glucose, and insulin levels in high-fat diet-induced Sprague–Dawley (SD) rats.

Methods

SD rats were randomly assigned to three groups: Group A, which comprised a normal-diet control group; Group B, which comprised a high-fat-fed group; and Group C, which comprised rats treated with UDCA combined with a high-fat diet. At the end of week 4, we performed oral glucose tolerance tests, measured liver enzymes, triglyceride (TG) and total cholesterol (TC) contents, identified morphological changes of the liver, and quantified the expression of major genes in fatty acid, glucose, and bile acid metabolic pathways using real-time polymerase chain reaction.

Results

In comparison to Group A, Group B had higher postprandial glucose, insulin, C-peptide, and hepatic TG and TC concentrations (all p < 0.05); metabolism-related genes were differentially expressed in Group B. In comparison to Group B, the values of these indices were all decreased in Group C (all p < 0.05); UDCA reversed the mRNA expression of metabolism-related genes in Group C (all p < 0.05).

Conclusion

UDCA administration decreased hepatic lipid content, blood glucose, and insulin levels in SD rats. Relevance for patients: UDCA may be helpful in the treatment of MASLD and its related comorbidities in clinical practice.

Zitieren

APA

Bai, X., Han, Y., Wei, L., Han, X., & Dong, F. (2026). Influence of ursodeoxycholic acid on hepatic lipid deposition, blood glucose, and insulin levels in high-fat -fed Sprague–Dawley rats. Journal of Clinical and Translational Research, 12(5), 026090015. https://doi.org/10.36922/jctr026090015

Vancouver

Bai X, Han Y, Wei L, Han X, Dong F. Influence of ursodeoxycholic acid on hepatic lipid deposition, blood glucose, and insulin levels in high-fat -fed Sprague–Dawley rats. Journal of Clinical and Translational Research. 2026;12(5):026090015. doi:10.36922/jctr026090015

BibTeX
@article{Bai2026,
  author = {Bai, Xiuping and Han, Yufeng and Wei, Lingyan and Han, Xiaojin and Dong, Feng},
  title = {Influence of ursodeoxycholic acid on hepatic lipid deposition, blood glucose, and insulin levels in high-fat -fed Sprague–Dawley rats},
  journal = {Journal of Clinical and Translational Research},
  year = {2026},
  volume = {12},
  number = {5},
  pages = {026090015},
  doi = {10.36922/jctr026090015}
}
Kostenlos starten →